Dermatology Update 2025

Learning Objectives:

• Recognize the clinical features and trichoscopic findings of frontal fibrosing alopecia to support early diagnosis and management.
• Discuss the immunologic mechanisms underlying prurigo nodularis and evaluate the role of emerging biologic therapies, including dupilumab and nemolizumab.
• Identify the hallmark clinical presentation of pityriasis rosea, including the herald patch and Christmas-tree distribution, and distinguish it from common mimickers.
• Differentiate fixed drug eruption from other drug-induced rashes by analyzing its recurrent site-specific presentation and post-inflammatory hyperpigmentation.
• Evaluate treatment options for granuloma annulare, comparing localized interventions with systemic therapies for generalized disease.

Dr. Asfa Akhtar has no actual or potential conflict of interest in relation to this program or presentation.

ACCREDITATION: The FOMA is accredited by the American Osteopathic Association to provide Osteopathic continuing medical education for Physicians.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Florida Osteopathic Medical Association (FOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

GRIEVANCE POLICY: The FOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to FOMA Executive Director Steve Winn, by calling the FOMA Office at 850-878-7364 or by mail to FOMA, 2544 Blairstone Pines Drive, Tallahassee, FL  32301, or by email to admin@foma.org